KMI vs PACB · P/E 24, rev $9.30B vs rev $76.2M
Kinder Morgan Inc (KMI) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
KMI currently screens at market cap $62.53B and trailing P/E 24.2. PACB currently screens at market cap $387.1M.
Not investment advice. Open the KMI and PACB stock pages for the full models.
Not investment advice.